126 related articles for article (PubMed ID: 8854949)
1. Serum alpha-fetoprotein concentrations in urban and rural Southern African blacks with hepatocellular carcinoma.
Kew MC; van Staden L; Bellingan A
Trop Gastroenterol; 1995; 16(4):11-5. PubMed ID: 8854949
[TBL] [Abstract][Full Text] [Related]
2. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks.
Bukofzer S; Stass PM; Kew MC; de Beer M; Groeneveld HT
Br J Cancer; 1989 Mar; 59(3):417-20. PubMed ID: 2467686
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in urban born blacks: frequency and relation to hepatitis B virus infection.
Kew MC; Kassianides C; Hodkinson J; Coppin A; Paterson AC
Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1339-41. PubMed ID: 3024771
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in rural southern African blacks.
Kew MC; Geddes EW
Medicine (Baltimore); 1982 Mar; 61(2):98-108. PubMed ID: 6174843
[No Abstract] [Full Text] [Related]
5. Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.
Johnson PJ; Portmann B; Williams R
Br Med J; 1978 Sep; 2(6138):661-3. PubMed ID: 81086
[TBL] [Abstract][Full Text] [Related]
6. Serum erythropoietin concentrations in patients with hepatocellular carcinoma.
Kew MC; Fisher JW
Cancer; 1986 Dec; 58(11):2485-8. PubMed ID: 2429757
[TBL] [Abstract][Full Text] [Related]
7. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Sato Y; Nakata K; Kato Y; Shima M; Ishii N; Koji T; Taketa K; Endo Y; Nagataki S
N Engl J Med; 1993 Jun; 328(25):1802-6. PubMed ID: 7684823
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity in chromosome 4q12-q13 in hepatocellular carcinoma in southern African blacks.
Leon M; Kew MC
Anticancer Res; 1996; 16(1):349-51. PubMed ID: 8615634
[TBL] [Abstract][Full Text] [Related]
9. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; Llovet JM; Assenat E; Brandi G; Pracht M; Lim HY; Rau KM; Motomura K; Ohno I; Merle P; Daniele B; Shin DB; Gerken G; Borg C; Hiriart JB; Okusaka T; Morimoto M; Hsu Y; Abada PB; Kudo M;
Lancet Oncol; 2019 Feb; 20(2):282-296. PubMed ID: 30665869
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study on the patterns of sequential fluctuation of serum alpha-fetoprotein level during progression from liver cirrhosis to hepatocellular carcinoma.
Imaeda T; Doi H
J Gastroenterol Hepatol; 1992; 7(2):132-5. PubMed ID: 1373964
[TBL] [Abstract][Full Text] [Related]
12. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Chen DS; Sung JL; Sheu JC; Lai MY; How SW; Hsu HC; Lee CS; Wei TC
Gastroenterology; 1984 Jun; 86(6):1404-9. PubMed ID: 6201411
[TBL] [Abstract][Full Text] [Related]
13. A comparison between des-gamma-carboxy prothrombin and alpha-fetoprotein as markers of hepatocellular carcinoma in southern African blacks.
King MA; Kew MC; Kuyl JM; Atkinson PM
J Gastroenterol Hepatol; 1989; 4(1):17-24. PubMed ID: 2485005
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma with and without cirrhosis. A comparison in southern African blacks.
Kew MC
Gastroenterology; 1989 Jul; 97(1):136-9. PubMed ID: 2470634
[TBL] [Abstract][Full Text] [Related]
15. Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas.
Peng SY; Lai PL; Chu JS; Lee PH; Tsung PT; Chen DS; Hsu HC
Hepatology; 1993 Jan; 17(1):35-41. PubMed ID: 7678574
[TBL] [Abstract][Full Text] [Related]
16. Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.
Lee HS; Chung YH; Kim CY
Hepatology; 1991 Jul; 14(1):68-72. PubMed ID: 1712341
[TBL] [Abstract][Full Text] [Related]
17. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N
BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606
[TBL] [Abstract][Full Text] [Related]
18. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
[TBL] [Abstract][Full Text] [Related]
19. alpha-Fetoprotein in liver disease.
Alexander MG; Purves LR; Kirsch RE; Bass NM; Gitlin N; Terblanche J; Saunders SJ
S Afr Med J; 1978 Mar; 53(12):433-6. PubMed ID: 79225
[TBL] [Abstract][Full Text] [Related]
20. Non-specificity of messenger RNA of alpha-fetoprotein in peripheral blood in detecting early spread of hepatocellular carcinoma in black Africans.
Kedda MA; Kew MC; Skelton M; Hodkinson J
J Gastroenterol Hepatol; 1998 Sep; 13(9):885-91. PubMed ID: 9794185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
